Chikungunya and Mayaro infective viruses in components of blood

Ana Beatriz Dos Anjos Souza1, Victória Thomazelli1, Luiz Tadeu Moraes Figueiredo1

  • 1Virology Research Center, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto, Brazil.

Abstract

Insights

Chikungunya and Mayaro viruses remain infectious in blood products, posing a transfusion risk. Development of diagnostic tests for donated blood is crucial to prevent transmission of these arboviruses.

Area of Science:

  • Virology
  • Transfusion Medicine
  • Public Health

Background:

  • Arboviruses, including Chikungunya and Mayaro, cause significant public health concerns due to sporadic and epidemic outbreaks.
  • High rates of asymptomatic infections and viremia in arbovirus-infected individuals pose a risk of transmission through blood transfusion.
  • Blood donors may unknowingly transmit these viruses, highlighting the need for robust screening methods.

Purpose of the Study:

  • To evaluate the infectivity and persistence of Chikungunya and Mayaro viruses in blood products.
  • To quantify viral load in plaque-forming units per milliliter (UFP/ml) within different blood components.
  • To assess the risk of transfusion-transmitted arboviruses.

Main Methods:

  • Utilized discarded blood bags, ensuring no compromise to clinical supply.
  • Infected blood bags with quantified Chikungunya and Mayaro viruses at levels consistent with viremia.
  • Processed infected blood into standard components: red blood cell concentrate, platelet concentrate, and fresh frozen plasma.

Main Results:

  • Chikungunya and Mayaro viruses maintained infectivity throughout the processing of blood components.
  • Infectious viruses were detected in red blood cell concentrate, platelet concentrate, and fresh frozen plasma after recommended storage periods.
  • The findings indicate a potential risk of transmitting Chikungunya and Mayaro viruses via transfusion of contaminated blood products.

Conclusions:

  • The study demonstrates the viability of Chikungunya and Mayaro viruses in blood products, posing a significant transfusion risk.
  • There is an urgent need for the development and implementation of sensitive diagnostic tests for these arboviruses in donated blood.
  • Implementing effective screening strategies is essential to prevent Chikungunya and Mayaro virus infections through blood transfusions.